tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

DNTH Stock Latest News

Dianthus participates in a conference call with William Blair
The FlyDianthus participates in a conference call with William Blair
20h ago
DNTH
Pipeline-in-a-Product Momentum: De-Risked Autoimmune Neurology Catalyst Path Justifies Buy Rating on Claseprubart Franchise
PremiumRatings
Pipeline-in-a-Product Momentum: De-Risked Autoimmune Neurology Catalyst Path Justifies Buy Rating on Claseprubart Franchise
12d ago
DNTH
Dianthus price target raised to $125 from $62 at Oppenheimer
PremiumThe Fly
Dianthus price target raised to $125 from $62 at Oppenheimer
12d ago
DNTH
Dianthus files $600M mixed securities shelf
PremiumThe Fly
Dianthus files $600M mixed securities shelf
13d ago
DNTH
Dianthus Therapeutics: Clinical Momentum, Pipeline Expansion, and Undervalued Catalysts Support Buy Rating
PremiumRatings
Dianthus Therapeutics: Clinical Momentum, Pipeline Expansion, and Undervalued Catalysts Support Buy Rating
27d ago
DNTH
Dianthus price target raised to $63 from $56 at Truist
PremiumThe FlyDianthus price target raised to $63 from $56 at Truist
1M ago
DNTH
Dianthus, Nanjing Leads Biolabs initiate Phase 1 trial of LBL-047
Premium
The Fly
Dianthus, Nanjing Leads Biolabs initiate Phase 1 trial of LBL-047
2M ago
DNTH
Dianthus price target raised to $47 from $40 at H.C. Wainwright
Premium
The Fly
Dianthus price target raised to $47 from $40 at H.C. Wainwright
3M ago
DNTH
Dianthus Therapeutics: Strong Financials and Promising Clinical Developments Justify Buy Rating
PremiumRatings
Dianthus Therapeutics: Strong Financials and Promising Clinical Developments Justify Buy Rating
3M ago
DNTH
Dianthus price target raised to $62 from $60 at Oppenheimer
PremiumThe Fly
Dianthus price target raised to $62 from $60 at Oppenheimer
3M ago
SNY
DNTH
Dianthus Therapeutics Reports Q3 2025 Financial Results
PremiumCompany Announcements
Dianthus Therapeutics Reports Q3 2025 Financial Results
3M ago
DNTH
Dianthus Therapeutics: Promising Pipeline and Strong Financials Justify Buy Rating
PremiumRatings
Dianthus Therapeutics: Promising Pipeline and Strong Financials Justify Buy Rating
3M ago
DNTH
Dianthus reports Q3 EPS (97c), consensus (90c)
PremiumThe FlyDianthus reports Q3 EPS (97c), consensus (90c)
3M ago
DNTH
Dianthus Therapeutics Reports Positive Phase 2 Results
Premium
Company Announcements
Dianthus Therapeutics Reports Positive Phase 2 Results
3M ago
8K
DNTH
Promising Clinical Data and Strategic Plans Position Dianthus Therapeutics as an Attractive Investment Opportunity
Premium
Ratings
Promising Clinical Data and Strategic Plans Position Dianthus Therapeutics as an Attractive Investment Opportunity
3M ago
DNTH
Dianthus Therapeutics Advances CIDP Treatment with DNTH103 Study
PremiumCompany Announcements
Dianthus Therapeutics Advances CIDP Treatment with DNTH103 Study
4M ago
DNTH
Dianthus Therapeutics Advances Phase 2 Study of DNTH103 for Neuropathy
PremiumCompany Announcements
Dianthus Therapeutics Advances Phase 2 Study of DNTH103 for Neuropathy
4M ago
DNTH
Dianthus Therapeutics: Strategic Positioning and Innovative Pipeline Justify Buy Rating
PremiumRatings
Dianthus Therapeutics: Strategic Positioning and Innovative Pipeline Justify Buy Rating
4M ago
DNTH
Dianthus Therapeutics’ Strategic Moves and Pipeline Potential Justify Buy Rating
PremiumRatings
Dianthus Therapeutics’ Strategic Moves and Pipeline Potential Justify Buy Rating
4M ago
DNTH
Dianthus Therapeutics Signs License Agreement with Nanjing Leads
PremiumCompany AnnouncementsDianthus Therapeutics Signs License Agreement with Nanjing Leads
4M ago
8K
DNTH
Dianthus enters exclusive license agreement with Leads Biolabs for DNTH212
Premium
The Fly
Dianthus enters exclusive license agreement with Leads Biolabs for DNTH212
4M ago
DNTH
3 Best Stocks to Buy Now, 10/14/2025, According to Top Analysts
Premium
Market News
3 Best Stocks to Buy Now, 10/14/2025, According to Top Analysts
4M ago
NOW
ARES

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >